NR2F6 promotes the malignant progression of neuroblastoma as an indicator of poor prognosis
Our results suggest that NR2F6 plays a crucial role in tumor-promoting effects and can be used as a potential prognostic marker for NB.
Authors
- Jun‐Yi Luo (ORCID: https://orcid.org/0000-0002-4767-1288)
- Yimeng Liu (ORCID: https://orcid.org/0000-0002-9433-5092)
- Liming Jin (ORCID: https://orcid.org/0000-0002-6695-7193)
- Jiayan Liu (ORCID: https://orcid.org/0000-0003-2798-8795)
- Jinkui Wang (ORCID: https://orcid.org/0000-0002-9719-0757)
- Chunnian Ren
- Mujie Li (ORCID: https://orcid.org/0000-0003-3140-6217)
- Tao Mi (ORCID: https://orcid.org/0000-0002-5244-1479)
- Xin Wu (ORCID: https://orcid.org/0009-0008-2292-4534)
- Dawei He (ORCID: https://orcid.org/0000-0002-1695-5886)
- Zhaoying Wang (ORCID: https://orcid.org/0009-0000-7718-888X)
- Zhaoxia Zhang (ORCID: https://orcid.org/0009-0007-2226-9560)
Institutions
- Dalian Medical University (CN)
- China International Science and Technology Cooperation (CN)
- Second Affiliated Hospital of Chongqing Medical University (CN)
- Children's Hospital of Chongqing Medical University (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- PLoS ONE
- Published
- 2025-05-27
- DOI
- https://doi.org/10.1371/journal.pone.0324334
- Primary Topic
- Neuroblastoma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Chongqing Science and Technology Commission